UJ

Active Director Director DIN 09571302
DIN 09571302 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Udit Jain

Data last updated:

Udit Jain is a Director at Humonyx Bioscience Private Limited (since 2022). The company operates in Chemicals. Humonyx Bioscience Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 09571302
Primary Designation Director
Industry Chemicals
First Appointment 13 Apr 2022
Oldest Company Age 4 yrs
Largest company Humonyx Bioscience Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Humonyx Bioscience Private Limited U24290DL2022PTC396628
Director13 Apr 20222022₹12.5 Lakh (FY 2025)Active

Board colleagues of Udit Jain

NameDINCompanyDesignation
Sandhya Trivedi09571313Humonyx Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Humonyx Bioscience Private Limited
Premium access

Shareholding and investment profile for Udit Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udit Jain

Udit Jain currently holds 1 directorship: Humonyx Bioscience Private Limited (Director, since 13 Apr 2022, revenue ₹12.5 Lakh (FY 2025)).

Udit Jain was first appointed on 13 Apr 2022 as Director at Humonyx Bioscience Private Limited.

The current boards of Udit Jain's companies include Sandhya Trivedi (Humonyx Bioscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available